Most diseases we think of as exotic begin in animals. Conservative estimates put the share of emerging human infections with animal origins at around 60 percent, with some analyses pushing that figure as high as 75 percent.1PMC. Zoonotic spillover: Understanding basic aspects for better prevention The jump from animal to human is called zoonotic spillover, and it is not random. A specific chain of conditions has to line up: the right reservoir host, the right environmental disturbance, the right genetic mutations in the pathogen, and often the right transportation network to carry the newly adapted germ around the world. Understanding each link in that chain helps explain why some spillover events fizzle out while others become pandemics.
Where New Diseases Originate
Spillover is defined as the cross-species transmission of a pathogen into a host population not previously infected.1PMC. Zoonotic spillover: Understanding basic aspects for better prevention The risk of such an event depends heavily on how common the pathogen is in its reservoir host, which is the animal species that carries the germ long-term without necessarily getting sick. Wild animals and livestock both serve as reservoirs, and the closer humans live or work alongside them, the more chances the pathogen has to make the leap. Farming, hunting, butchering, and even casual habitat overlap all create opportunities for viruses, bacteria, and parasites to encounter human cells for the first time.
Not every spillover leads to an outbreak. Most of the time the pathogen infects one person, causes illness or doesn’t, and goes no further because it hasn’t yet evolved the ability to spread efficiently between people. The dangerous scenario is when a pathogen manages to cross into humans and then picks up the capacity for sustained human-to-human transmission. That sequence turned SARS-CoV-1, HIV, and Ebola from isolated animal infections into global health crises.
Why Bats Keep Showing Up
Bats are natural hosts for a remarkable number of viruses, including relatives of Ebola, SARS, MERS, and Nipah. What makes them unusual is that they tolerate these infections without developing clinical symptoms. Even experimental inoculation of bats with some of the deadliest known viruses has produced only subclinical infections.2Cell Metabolism. How Bats Spark Major Advances in Immunology, Longevity, and Human Health They act as silent reservoirs, maintaining viral populations that periodically spill over into other mammals and, eventually, humans.
Recent research has started to explain the mechanism behind this viral tolerance. Bat immune systems appear to have specifically dampened the inflammatory signaling pathway mediated by Toll-like receptor 2. Lab experiments showed that the ability of this receptor to pair with its partner receptors was significantly reduced in bat cells compared to other mammals, leading to a weaker inflammatory response.3PubMed Central. Dampened TLR2-mediated Inflammatory Signaling in Bats In simple terms, bats have turned down the volume on part of their immune alarm system. This lets them coexist with viruses that would cause severe inflammation and organ damage in other species. The trade-off is that bats become incubators for pathogens that are primed to cause havoc the moment they enter a host with a normal inflammatory response.
Intermediate Hosts as Amplifiers
A pathogen rarely jumps straight from a bat to a human in a way that sparks an epidemic. More often, an intermediate host sits between the original reservoir and people. This middle animal can serve two roles: it can amplify the pathogen by allowing it to replicate to higher levels, or it can act as a vessel for genetic variation, giving the pathogen opportunities to mutate into forms better suited for human infection.4PubMed. Effect of Intermediate Hosts on Emerging Zoonoses Civets played this amplifier role for SARS-CoV-1; dromedary camels do the same for MERS. In each case, the intermediate host brought the virus into closer contact with humans and gave it a biological stepping stone.
Identifying the intermediate host is one of the hardest parts of tracing a new outbreak. Genetic sequencing can narrow the search, but it often takes years of sampling wild and domestic animal populations to pin down the chain. In some cases the intermediate host is never confirmed with certainty, which complicates efforts to prevent the next spillover from the same source.
Deforestation and Land Use Change
When forests are cleared for farming, logging, or urban expansion, the boundary between human communities and wildlife shrinks. Animals that previously lived deep in intact habitat are pushed to the edges, where they forage closer to livestock and human settlements. This proximity creates new opportunities for pathogen exchange. A systematic review of zoonotic disease emergence in mammals found that deforestation, urbanization, and agricultural intensification all accelerate the spread of pathogens and increase the probability of transmission to humans.5PubMed Central. Emerging zoonotic diseases originating in mammals: a systematic review of effects of anthropogenic land-use change
The mechanism is not just about proximity. Habitat destruction also reduces biodiversity. When a diverse community of species is intact, pathogens get diluted across many hosts, some of which are poor at transmitting the infection onward. Remove that diversity and the remaining species, often generalists like rodents and certain bat species, tend to be the ones most likely to carry and shed dangerous pathogens. Studies at a global scale have confirmed that deforestation and biodiversity loss favor the populations of reservoir species and disease vectors, ultimately increasing human contact with both.6PubMed Central. Outbreaks of Vector-Borne and Zoonotic Diseases Are Associated With Changes in Forest Cover and Oil Palm Expansion at Global Scale Research modeling the relationship between habitat area and disease risk has further demonstrated that the rate at which new human cases appear is directly tied to how much wildlife habitat remains.7Journal of Environmental Economics and Management. Habitat loss and the risk of disease outbreak
Urbanization compounds this. As cities expand into formerly rural land, rodents thrive on human waste and food supplies. Environmental and anthropogenic factors like urbanization and deforestation are increasingly linked to rising outbreaks of rodent-borne diseases, which include hantaviruses, Lassa fever, and leptospirosis.8PubMed Central. The Hidden Threat: Rodent-Borne Viruses and Their Impact on Public Health
Climate Change and Expanding Vector Ranges
Mosquitoes, ticks, and other disease-carrying arthropods are constrained by temperature. As global temperatures rise, the geographic zones where these vectors can survive and reproduce are expanding. Modeling studies project that the mosquitoes responsible for transmitting dengue, Zika, and chikungunya will shift poleward as their optimal temperature ranges move, potentially exposing populations in previously unaffected regions.9PLOS Neglected Tropical Diseases. Global expansion and redistribution of Aedes-borne virus transmission risk with climate change The Asian tiger mosquito, for instance, is already established across southern Europe and parts of the eastern United States, well outside its original tropical range.
Malaria transmission is also affected. In highland areas of Africa, the Eastern Mediterranean, and the Americas, projections show that the length of the malaria transmission season could increase by up to about one and a half additional months by the end of the century under high-emission scenarios, with an average increase of roughly half a month.10The Lancet Planetary Health. Projecting the risk of mosquito-borne diseases in a warmer and more populated world: a multi-model, multi-scenario intercomparison modelling study For communities at altitude who have never dealt with malaria, even a short transmission season represents a serious new threat, because they lack both the public health infrastructure and the partial immunity that endemic-region populations develop over time.
Warming temperatures may also be creating new opportunities for fungal pathogens. Rising environmental temperatures could help fungi adapt to high-heat environments, potentially making them better equipped to survive at human body temperature and increasing their ability to cause disease.11The Lancet Infectious Diseases. Climate change, natural disasters, and fungal infections The emergence of drug-resistant Candida auris, a fungal pathogen that appeared independently on multiple continents around the same time, has prompted researchers to investigate whether climate-driven thermal adaptation played a role.
Wildlife Trade and Live Animal Markets
Markets where live animals are sold, slaughtered, and butchered in close quarters with customers create ideal mixing conditions for pathogens. A classification framework for wet markets identified six key risk factors: the presence of high-risk animal species, live animals kept on site, poor hygiene, large market size, dense interspecies mixing, and long supply chains that move animals across wide geographies.12PubMed Central. A better classification of wet markets is key to safeguarding human health and biodiversity When wild-caught mammals from different regions and different species are stacked in cages next to each other, a virus circulating in one species can hop to another that would never encounter it in the wild, and from there into a human butcher or buyer.
The World Health Organization has called for banning the sale of live, wild-caught mammalian species in markets unless adequate risk assessment and effective regulations are in place.13PubMed. A scoping review of live wildlife trade in markets worldwide The challenge is that these markets are important for food security in many regions and operate within deeply rooted cultural practices. Blanket bans are politically difficult and can push the trade underground, where oversight disappears entirely. The more pragmatic approach has been to target specific high-risk practices, like keeping live wild mammals alongside poultry, rather than shutting down entire markets.
How Pathogens Adapt to Humans
Crossing into a human cell is only part of the challenge for an animal pathogen. To spread efficiently between people, the pathogen usually needs specific genetic changes. Influenza viruses illustrate this well. Avian influenza strains like H7N9 prefer to bind to receptors in bird airways, which are chemically different from the receptors lining human airways. Research has shown that as few as three amino acid mutations in the virus’s surface protein can switch H7N9 from avian-type to human-type receptor binding, a shift that would be required for efficient transmission among humans.14PLOS Pathogens. Three mutations switch H7N9 influenza to human-type receptor specificity
That sounds alarming, but the picture is more reassuring than it first appears. For highly pathogenic H5N1 bird flu, studies have found that even when mutations switch the receptor binding preference, the resulting viruses often replicate poorly and show no improvement in transmission efficiency compared to the original strain.15PubMed Central. Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses The virus needs multiple mutations to accumulate within a single genome to achieve full human adaptation, and acquiring all of them during a single human infection is rare.16PubMed Central. Phenotypic Effects of Substitutions within the Receptor Binding Site of Highly Pathogenic Avian Influenza H5N1 Virus Observed during Human Infection Each mutation may come with a fitness cost, like reduced stability or slower replication, making it harder for the virus to accumulate the full set it needs. This is one reason H5N1 has caused sporadic human cases for decades without triggering a pandemic, though it remains a closely watched threat.
Evolutionary theory also predicts something counterintuitive about new pathogens: they may be more virulent at the start of an epidemic than they will be later. Early in an outbreak, when nearly everyone is susceptible, natural selection can favor strains that replicate aggressively and transmit fast, even if they burn out their hosts quickly. Over time, as the susceptible population shrinks, the tradeoff between transmission speed and host survival tends to favor less virulent strains.17PubMed Central. Transient virulence of emerging pathogens This “transient virulence” effect helps explain why some outbreaks appear to mellow over time, though it is not guaranteed.
Air Travel and the Speed of Global Spread
Once a pathogen can transmit between people, modern transportation determines how fast it reaches every continent. The 2009 H1N1 influenza strain reached 24 countries and 40 U.S. states within just two weeks of being first reported, propelled in large part by the connectivity of the global airline network.18PLOS ONE. Predictive Power of Air Travel and Socio-Economic Data for Early Pandemic Spread A century earlier, the 1918 flu took months to traverse the same geography by ship and rail.
Research on the dispersal of SARS-CoV-2 variants confirmed this relationship in granular detail. The time it took for a new variant to appear in a given country was positively correlated with how far that country sat from the variant’s origin along the airline network. Countries directly connected by heavy air traffic to the origin saw the variant first; those reachable only through multiple hub connections saw it later.19Cell. The global dispersal of SARS-CoV-2 variants of concern The structure of the airline network matters too: a variant emerging from a hub country with direct flights to many destinations spreads in a star-shaped pattern, while one from a less-connected country follows a slower, stepwise path through intermediary hubs.
Why Some Populations Are More Vulnerable
When a pathogen is genuinely new to humans, nobody has prior immunity. That immunological blank slate is a major reason novel diseases can sweep through populations so quickly. But “new” is a matter of degree. For the current H5N1 bird flu clade circulating in dairy cattle and poultry, researchers assessed pre-existing immunity across nearly 1,800 blood samples from people in the United States. They found that neutralizing antibodies and antibodies targeting the main surface protein of H5N1 were low across all age groups. However, there were substantial cross-reactive antibodies to a different surface protein, neuraminidase, and antibodies targeting a conserved region of the hemagglutinin stalk were prevalent and increased with age.20PubMed Central. Pre-existing cross-reactive immunity to highly pathogenic avian influenza 2.3.4.4b A(H5N1) virus in the United States
What this means practically is that while most people lack the kind of targeted immunity that would block H5N1 infection outright, older adults who have been exposed to more influenza strains over their lifetimes carry some broadly reactive antibodies that might offer partial protection. Whether that partial immunity would translate into milder disease during a pandemic remains an open question, but it is a data point pandemic planners factor into their risk assessments.
Insecticide Resistance and Failing Vector Control
For vector-borne diseases, the front line of defense has long been insecticide-treated bed nets, indoor spraying, and larvicides. But insect populations adapt. Insecticide resistance has emerged in every major group of disease-carrying insects, and while the underlying mechanisms are similar across species, each resistance problem involves a complex and potentially unique pattern of resistant subpopulations.21PubMed Central. Insecticide resistance and vector control
Modeling work suggests that even relatively modest levels of resistance can cause control interventions to fail, and that resistance spreads faster when insecticides target larval stages rather than adult mosquitoes.22PubMed Central. Modelling the impact of insecticide-based control interventions on the evolution of insecticide resistance and disease transmission This creates a treadmill effect: public health programs deploy a chemical, resistance develops, the chemical stops working, and a replacement must be found. Meanwhile, invasive mosquito species complicate matters further. The Asian tiger mosquito has displaced native mosquitoes in parts of the Americas and elsewhere through reproductive interference, effectively replacing a less-efficient disease vector with a more competent one.23PubMed. Satyrization and satyrization-resistance in competitive displacements of invasive mosquito species
When Humans Infect Animals Back
Spillover is not a one-way street. The transmission of pathogens from humans to animals, called reverse zoonosis or spillback, can establish new infections in animal populations and threaten wildlife conservation.24PubMed Central. A systematic review on reverse-zoonosis: Global impact and changes in transmission patterns A systematic review of documented cases found that wildlife accounted for about half of the reported reverse-zoonotic infections, livestock for roughly 43 percent, and companion animals for about 23 percent.25PLOS ONE. Reverse Zoonotic Disease Transmission (Zooanthroponosis): A Systematic Review of Seldom-Documented Human Biological Threats to Animals
The concern is not just animal welfare. Once a human pathogen establishes itself in a new animal reservoir, it can continue mutating in that host and potentially spill back into humans in an altered form. During the COVID-19 pandemic, SARS-CoV-2 infected farmed mink in several countries, evolved new mutations in those mink populations, and in at least one documented case transmitted a mink-adapted variant back to farm workers. This ping-pong effect between species creates opportunities for the virus to explore mutations it might never have encountered in an exclusively human chain of transmission.
Ancient Pathogens Thawing from Permafrost
A more speculative but increasingly studied pathway for disease emergence involves the thawing of ancient permafrost. Researchers have successfully revived viruses from Siberian permafrost samples tens of thousands of years old. Preliminary characterizations have identified 13 new viruses isolated from seven different ancient permafrost samples, along with material from the Lena River and Kamchatka cryosol.26PubMed Central. An Update on Eukaryotic Viruses Revived from Ancient Permafrost The viruses recovered so far infect amoebas, not humans, but their viability after millennia in ice demonstrates that permafrost can preserve infectious agents far longer than anyone expected.
Whether dangerous human or animal pathogens lurk in permafrost remains uncertain. A real-world precedent already exists: in 2016, a heatwave in Siberia thawed a reindeer carcass that had been frozen since a 1941 anthrax outbreak, releasing viable anthrax spores that killed a child and sickened dozens. As Arctic warming accelerates and permafrost that has been frozen for thousands of years begins to degrade, the probability of encountering preserved pathogens increases. The risk is likely small compared to the ongoing threat from deforestation-driven spillover and climate-expanded vector ranges, but it is no longer purely theoretical.
Laboratory Safety and Accidental Release
Some of the most dangerous pathogens in the world are studied in high-containment laboratories, and the question of whether that research could itself become a source of emergence is a legitimate one. An analysis of biosafety policy found that while official frameworks emphasize physical security to prevent terrorism-related theft, they often fail to sufficiently address the prevention of laboratory accidents, accidental releases, and other incidents during routine research.27Safety Science. Biotechnological research on the most dangerous pathogens: Challenges for risk governance and safety management Weaknesses identified include inadequate federal oversight, poor siting decisions, breakdowns in reporting, and secrecy policies that hinder organizational learning.
Researchers working on potential pandemic pathogens have called for explicit risk-benefit assessments before such work is permitted or funded, along with improved biosafety enforcement and harmonized criteria across government agencies and international borders.28PubMed Central. Rethinking biosafety in research on potential pandemic pathogens The debate is not about whether such research has value, it clearly can, but about whether the safeguards match the stakes. A lab accident involving a flu strain engineered for higher transmissibility in mammals, for example, could spark the very pandemic the research was meant to help prevent.
The One Health Approach to Prevention
Because so many of these emergence pathways involve interactions between humans, animals, and ecosystems, effective prevention requires a framework that looks at all three simultaneously. This is the idea behind the One Health approach, which brings together public health, veterinary medicine, animal management, and ecological science to address disease threats at their source rather than waiting for a pathogen to show up in human hospitals.29PubMed Central. One Health, emerging infectious diseases and wildlife: two decades of progress?
In practice, One Health means things like establishing multisectoral laboratory working groups that actively survey humans, animals, and environmental samples in tandem, sharing data across sectors rather than siloing it within human-health or veterinary agencies.30PubMed Central. Enhancing Global Health Security in Sub-Saharan Africa: The case for integrated One Health surveillance against zoonotic diseases and environmental threats It means wildlife biologists flagging unusual die-offs to epidemiologists, and agricultural inspectors sharing data with public health labs. The concept has been around for roughly two decades now, and while adoption has been uneven, the approach has gained traction in Sub-Saharan Africa and Southeast Asia, regions where the overlap between dense human populations, high wildlife biodiversity, and rapid land use change makes the need most acute.31PubMed Central. One Health: enabler of effective prevention, control and elimination of emerging and re-emerging infectious diseases
The biggest obstacle is institutional. Ministries of health, agriculture, and environment operate with separate budgets, separate mandates, and separate chains of command. Getting them to share data in real time, let alone coordinate policy, requires sustained political will that often materializes only after an outbreak has already started. The irony of disease emergence is that the conditions that create it, habitat destruction, intensive farming, inadequate vector control, and gaps in surveillance, are all problems we broadly know how to address. The bottleneck is rarely scientific knowledge. It is whether that knowledge gets translated into coordinated action before the next pathogen makes its jump.